Report cover image

A Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy)

Publisher Market Research Future
Published Nov 08, 2024
Length 131 Pages
SKU # RESFT19339448

Description

Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032


In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, the E-Visa Market industry is expected to increase from USD 1,030.5 million in 2024 to USD 2,395.2 million by 2032. As more and more tourists choose to apply for visas online, the e-Visa market continues to grow. In addition, because of an increase in identity fraud, which will ultimately result in more air travel, there is a growing need for more supportive policies, cutting-edge airport infrastructure, and sophisticated verification techniques.

The cost of traveling abroad has decreased, making it more accessible. Consequently, there is an increase in demand for visas. These electronic visas satisfy this need by offering a quick and simple way to get the documents you need. This is comparable to the lengthy and inconvenient standard visa application procedures that prospective tourists must endure. E-Visas streamline the application process by reducing paperwork, processing time, and the need to visit embassies or consulates. All of these facilitate travel, which increases demand for visas.

Perspectives on Market Segments
The E-Visa market has been divided into two segments based on component: services and software.
The market has been divided into segments based on application, including travel, government/foreign affairs, students/educational visas, and others.
The E-Visa market has been divided into three segments based on platform: desktop, smartphone, and tablet.

Regional Perspectives
North America, Europe, Asia-Pacific, the Middle East and Africa, and South America are the regions for which the study offers market insights. The United States, Canada, and Mexico make up North America. Due to the huge volume of traffic entering and leaving the region, the e-Visa market in North America is expanding. Among the various nations that make up North America are the United States, Canada, and Mexico, each of which has its own E-Visa criteria.

Because so many people travel to and from the Asia Pacific region, it is a large market and a major consumer of e-Visa. Each of the numerous nations that make up the Asia Pacific area has unique requirements for E-Visas. With millions of people applying each year for various visas, including work, student, and tourist visas, China is one of the biggest markets for passports and visas in the region.

The study's Europe region includes the UK, Germany, France, and the rest of Europe. Because Europe is a prominent destination for immigration and travel, there is a sizable demand for e-visas there. Each of the numerous nations that make up Europe has its own strict E-Visa regulations. The European Union, or EU for short, is the market in Europe most impacted by passports and visas.

Important Players
Top players in the E-Visa market include Gemalto N V, 4G Identity Solutions Pvt. Ltd, VFS Global, Securiport LLC, Swiss Authentis S.A., Mühlbauer Group, BLS International, Scicom (MSC) Bhd, Canadian Bank Note Company, Limited (CBN), Cserve Technologies, IVisa.com, VisaHQ, Travisa Visa Service Inc., ItsEasy Passport & Visa Services, and Gemalto N V.

Table of Contents

131 Pages
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.5.2 Primary Research: Number Of Interviews Conducted
3.5.3 Primary Research: Regional Coverage
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Type
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
3.9 Teams And Analyst Contribution
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing Incidences Of Cancer And Rare Disorders
4.2.2 Increasing Approval For Gene And Cell Therapy Products
4.3 Restraints
4.3.1 Clinical Trial Failure Associated With Gene And Cell Therapy
4.4 Opportunity
4.4.1 Growing Investment In The Field Of Gene And Cell Therapy
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Threat Of New Entrants
5.1.2 Bargaining Power Of Suppliers
5.1.3 Threat Of Substitutes
5.1.4 Bargaining Power Of Buyers
5.1.5 Intensity Of Rivalry
5.2 Impact Of Covid-19 On The Global Cell And Gene Therapy Market
6 Global Cell And Gene Therapy Market, By Therapy Type
6.1 Overview
6.2 Cell Therapy
6.2.1 Autologous
6.2.2 Allogeneic
6.3 Gene Therapy
6.3.1 Ex Vivo
6.3.2 In Vivo
7 Global Cell And Gene Therapy Market, By Application
7.1 Overview
7.2 Cancer
7.3 Neurological Disorders
7.4 Cardiovascular Disorders
7.5 Rare Diseases
7.6 Ophthalmology
7.7 Blood Disorders
7.8 Others
8 Global Cell And Gene Therapy Market, By Region
8.1 Overview
8.2 North America
8.2.1 Us
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 Uk
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest Of Europe
8.4 Asia-pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest Of Asia-pacific
8.5 Rest Of The World
8.5.1 Middle East & Africa
8.5.2 South America
9 Competitive Landscape
9.1 Introduction
9.2 Market Share Analysis, 2022
9.3 Competitor Dashboard
9.4 Public Players Stock Summary
9.5 Comparative Analysis: Key Players Finanical
9.6 Key Developments & Growth Strategies
9.6.1 Product Launch / Product Approval
9.6.2 Collaboration
9.6.3 Agreement
9.6.4 Expansion
10 Company Profiles
10.1 Novartis Ag
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products Offered
10.1.4 Key Developments
10.1.5 Swot Analysis
10.1.6 Key Strategies
10.2 Bristol-myers Squibb Company
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products Offered
10.2.4 Key Developments
10.2.5 Swot Analysis
10.2.6 Key Strategies
10.3 Amgen Inc.
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Products Offered
10.3.4 Key Developments
10.3.5 Key Strategies
10.4 Aurion Biotech
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products Offered
10.4.4 Key Developments
10.4.5 Key Strategies
10.5 Sarepta Therapeutics, Inc.
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products Offered
10.5.4 Key Developments
10.5.5 Key Strategies
10.6 Ferring B.V.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products Offered
10.6.4 Key Developments
10.6.5 Swot Analysis
10.6.6 Key Strategies
10.7 Sibiono Genetech Co. Ltd., Shenzhen (Sibiono)
10.7.1 Company Overview
10.7.2 Products Offered
10.7.3 Key Developments
10.7.4 Key Strategies
10.8 Bluebird Bio, Inc.
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products Offered
10.8.4 Key Developments
10.8.5 Swot Analysis
10.8.6 Key Strategies
10.9 Kite Pharmaceuticals, Inc.
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products Offered
10.9.4 Key Developments
10.9.5 Swot Analysis
10.9.6 Key Strategies
10.10 Janssen Global Services
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products Offered
10.10.4 Key Developments
10.10.5 Key Strategies
11 Data Citations
List Of Tables
Table 1 Qfd Modeling For Market Share Assessment
Table 2 Major Cell And Gene Therapy Approved Products
Table 3 Global Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 4 Global Cell And Gene Therapy Market, For Cell Therapy, By Region, 2021–2032 (Usd Million)
Table 5 Global Cell And Gene Therapy Market, For Cell Therapy, By Type, 2021–2032 (Usd Million)
Table 6 Global Cell And Gene Therapy Market, For Autologous, By Region, 2021–2032 (Usd Million)
Table 7 Global Cell And Gene Therapy Market, For Allogeneic, By Region, 2021–2032 (Usd Million)
Table 8 Global Cell And Gene Therapy Market, For Gene Therapy, By Region, 2021–2032 (Usd Million)
Table 9 Global Cell And Gene Therapy Market, For Gene Therapy, By Type, 2021–2032 (Usd Million)
Table 10 Global Cell And Gene Therapy Market, For Ex Vivo, By Region, 2021–2032 (Usd Million)
Table 11 Global Cell And Gene Therapy Market, For In Vivo, By Region, 2021–2032 (Usd Million)
Table 12 Global Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 13 Global Cell And Gene Therapy Market, For Cancer, By Region, 2021–2032 (Usd Million)
Table 14 Global Cell And Gene Therapy Market, For Neurological Disorders, By Region, 2021–2032 (Usd Million)
Table 15 Global Cell And Gene Therapy Market, For Cardiovascular Disorders, By Region, 2021–2032 (Usd Million)
Table 16 Global Cell And Gene Therapy Market, For Rare Diseases, By Region, 2021–2032 (Usd Million)
Table 17 Global Cell And Gene Therapy Market, For Ophthalmology, By Region, 2021–2032 (Usd Million)
Table 18 Global Cell And Gene Therapy Market, For Blood Disorders, By Region, 2021–2032 (Usd Million)
Table 19 Global Cell And Gene Therapy Market, For Others, By Region, 2021–2032 (Usd Million)
Table 20 Global Cell And Gene Therapy Market, By Region, 2019–2032 (Usd Million)
Table 21 North America: Cell And Gene Therapy Market, By Country, 2019–2032 (Usd Million)
Table 22 North America: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 23 North America: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 24 North America: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 25 North America: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 26 Us: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 27 Us: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 28 Us: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 29 Us: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 30 Canada: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 31 Canada: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 32 Canada: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 33 Canada: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 34 Europe: Cell And Gene Therapy Market, By Country, 2019–2032 (Usd Million)
Table 35 Europe: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 36 Europe: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 37 Europe: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 38 Europe: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 39 Germany: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 40 Germany: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 41 Germany: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 42 Germany: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 43 France: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 44 France: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 45 France: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 46 France: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 47 Uk: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 48 Uk: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 49 Uk: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 50 Uk: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 51 Italy: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 52 Italy: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 53 Italy: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 54 Italy: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 55 Spain: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 56 Spain: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 57 Spain: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 58 Spain: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 59 Rest Of Europe: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 60 Rest Of Europe: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 61 Rest Of Europe: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 62 Rest Of Europe: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 63 Asia-pacific: Cell And Gene Therapy Market, By Country, 2019–2032 (Usd Million)
Table 64 Asia-pacific: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 65 Asia-pacific: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 66 Asia-pacific: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 67 Asia-pacific: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 68 China: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 69 China: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 70 China: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 71 China: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 72 India: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 73 India: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 74 India: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 75 India: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 76 Japan: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 77 Japan: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 78 Japan: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 79 Japan: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 80 Australia: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 81 Australia: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 82 Australia: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 83 Australia: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 84 South Korea: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 85 South Korea: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 86 South Korea: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 87 South Korea: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 88 Rest Of Asia-pacific: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 89 Rest Of Asia-pacific: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 90 Rest Of Asia-pacific: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 91 Rest Of Asia-pacific: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 92 Rest Ot The World: Cell And Gene Therapy Market, By Region, 2019–2032 (Usd Million)
Table 93 Rest Ot The World: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 94 Rest Ot The World: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 95 Rest Ot The World: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 96 Rest Ot The World: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 97 Middle East & Africa: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 98 Middle East & Africa: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 99 Middle East & Africa: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 100 Middle East & Africa: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 101 South America: Cell And Gene Therapy Market, By Therapy Type, 2019–2032 (Usd Million)
Table 102 South America: Cell And Gene Therapy Market, For Cell Therapy, By Type, 2019–2032 (Usd Million)
Table 103 South America: Cell And Gene Therapy Market, For Gene Therapy, By Type, 2019–2032 (Usd Million)
Table 104 South America: Cell And Gene Therapy Market, By Application, 2019–2032 (Usd Million)
Table 105 Public Players Stock Summary
Table 106 Comparative Analysis: Key Players Finanical
Table 107 Product Launch/ Product Approval
Table 108 Collaboration
Table 109 Agreement
Table 110 Expansion
Table 111 Novartis Ag: Product Offered
Table 112 Novartis Ag.: Key Developments
Table 113 Bristol-myers Squibb Company.: Product Offered
Table 114 Bristol-myers Squibb Company.: Key Developments
Table 115 Amgen Inc.: Product Offered
Table 116 Aurion Biotech: Product Offered
Table 117 Aurion Biotech: Key Developments
Table 118 Sarepta Therapeutics, Inc.: Product Offered
Table 119 Sarepta Therapeutics, Inc.: Key Developments
Table 120 Ferring B.V.: Product Offered
Table 121 Ferring B.V.: Key Developments
Table 122 Sibiono Genetech Co. Ltd., Shenzhen (Sibiono).: Product Offered
Table 123 Bluebird Bio, Inc.: Products Offered
Table 124 Bluebird Bio, Inc.: Key Developments
Table 125 Kite Pharmaceuticals, Inc.: Products Offered
Table 126 Janssen Global Services: Products Offered
Table 127 Janssen Global Services: Key Developments
List Of Figures
Figure 1 Global Cell And Gene Therapy Market: Structure
Figure 2 Global Cell And Gene Therapy Market: Market Growth Factor Analysis (2022-2032)
Figure 3 Driver Impact Analysis (2023-2032)
Figure 4 Restraint Impact Analysis (2022-2032)
Figure 5 Porter's Five Forces Analysis: Global Cell And Gene Therapy Market
Figure 6 Global Cell And Gene Therapy Market; Therapy Type Segment Attractiveness, (Usd Million)
Figure 7 Global Cell And Gene Therapy Market, By Therapy Type, 2023 & 2032 (Usd Million)
Figure 8 Global Cell And Gene Therapy Market Share (%), By Therapy Type, 2022
Figure 9 Global Cell And Gene Therapy Market; Application Segment Attractiveness, (Usd Million)
Figure 10 Global Cell And Gene Therapy Market, By Application, 2023 & 2032 (Usd Million)
Figure 11 Global Cell And Gene Therapy Market Share (%), By Application, 2022
Figure 12 Global Cell And Gene Therapy Market, By Region, 2022 & 2032 (Usd Million)
Figure 13 Global Cell And Gene Therapy Market Share (%), By Region, 2022
Figure 14 North Ameica Market Analysis: Cell And Gene Therapy Market, 2019-2032 (Usd Million)
Figure 15 North America: Cell And Gene Therapy Market, By Country, 2022 & 2032 (Usd Million)
Figure 16 North America: Cell And Gene Therapy Market Share (%), By Country, 2022
Figure 17 Europe Market Analysis: Cell And Gene Therapy Market, 2019-2032 (Usd Million)
Figure 18 Europe: Cell And Gene Therapy Market, By Region, 2022 & 2032 (Usd Million)
Figure 19 Europe: Cell And Gene Therapy Market Share (%), By Region, 2022
Figure 20 Asia-pacific Market Analysis: Cell & Gene Therapy Market, 2019-2032 (Usd Million)
Figure 21 Asia-pacific: Cell And Gene Therapy Market, By Country, 2022 & 2032 (Usd Million)
Figure 22 Asia-pacific: Cell And Gene Therapy Market Share (%), By Country, 2022
Figure 23 Rest Of The World Market Analysis: Cell And Gene Therapy Market, 2019-2032 (Usd Million)
Figure 24 Rest Ot The World: Cell And Gene Therapy Market, By Region, 2022 & 2032 (Usd Million)
Figure 25 Rest Ot The World: Cell And Gene Therapy Market Share (%), By Region, 2022
Figure 26 Cell And Gene Therapy Market Players: Competitive Analsis, 2022
Figure 27 Competitor Dashboard: Global Cell And Gene Therapy Market
Figure 28 Novartis Ag: Financial Overview Snapshot
Figure 29 Novartis Ag.: Swot Analysis
Figure 30 Bristol-myers Squibb Company: Financial Overview Snapshot
Figure 31 Bristol-myers Squibb Company.: Swot Analysis
Figure 32 Amgen Inc.: Financial Overview Snapshot
Figure 33 Sarepta Therapeutics, Inc.: Financial Overview Snapshot
Figure 34 Ferring B.V.: Financial Overview Snapshot
Figure 35 Ferring B.V.: Swot Analysis
Figure 36 Bluebird Bio, Inc.: Financial Overview Snapshot
Figure 37 Bluebird Bio, Inc.: Swot Analysis
Figure 38 Kite Pharmaceuticals, Inc.: Swot Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us